Antibiotic resistance and antibiotic development
Author:
- Brad SpellbergBSBrad Spellberg
- 1 April 2008
- journal article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 8 (4) , 211-212
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Will longer antimicrobial patents improve global public health?The Lancet Infectious Diseases, 2007
- Societal Costs Versus Savings from Wild-Card Patent Extension Legislation to Spur Critically Needed Antibiotic DevelopmentInfection, 2007
- Anti-infective research and development—problems, challenges, and solutionsThe Lancet Infectious Diseases, 2007
- Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2006
- Resistance to Antibiotics: Are We in the Post-Antibiotic Era?Archives of Medical Research, 2005
- Trends in Antimicrobial Drug Development: Implications for the FutureClinical Infectious Diseases, 2004
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Humans as the World's Greatest Evolutionary ForceScience, 2001